Korenberg Matthew E sold LGND
May 13, 2024 · Form 4 insider transaction
Korenberg Matthew E sold 3,440 shares of Ligand Pharmaceuticals Incorporated at $84.54 per share, a transaction worth $290.8K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
3,440
Price
$84.54
Total value
$290.8K
InsiderKorenberg Matthew E
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMay 13, 2024
Filing dateMay 15, 2024
Shares owned after100,421
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $84.5000 to $84.8750. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.